Disclosure under Regulation 30 of SEBI (LODR) 2015, regarding Press release viz. "Dr. Reddy''s Laboratories to Ring the Closing Bell at New York Stock Exchange."
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Reddy's Laboratories has been invited to ring the Closing Bell at the New York Stock Exchange on May 29, 2026, marking 25 years since its NYSE listing in April 2001. The company was the first pharmaceutical company in Asia (outside Japan) to list on the NYSE. Chairman Satish Reddy and senior management including CEO Erez Israeli and CFO M.V. Narasimham will attend the ceremony. The event celebrates the company's global governance, transparency, and commitment to bringing affordable innovative medicines to patients worldwide. The ceremony will be livestreamed on NYSE.com and YouTube.
This is a ceremonial milestone announcement with no direct financial implications. It highlights Dr. Reddy's 25-year track record on the NYSE and may boost investor sentiment and global brand visibility, but does not affect company fundamentals or near-term stock performance.